Status:
RECRUITING
Controls and Healthy Vasculature Initiative
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Vascular And Immunologic Diseases
Healthy Volunteers
Eligibility:
All Genders
18-90 years
Brief Summary
Background: Diseases involving blood, blood vessels, and immune systems are leading causes of death in the United States. Researchers studying these diseases need to compare blood samples from both h...
Detailed Description
Study Description: This study will serve to provide tissue samples from individuals with healthy vasculature for mechanistic studies of vascular inflammation and thrombosis. Objectives: Primary Obj...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures
- Aged 18 years and older
- Ability of subject to understand and the willingness to sign a written informed consent document
- Self-reported in good general health
- EXCLUSION CRITERIA:
- An individual who, by self-report, meets the following criteria will be excluded from participation in this study:
- Current pregnancy or lactation
Exclusion
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2032
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05403151
Start Date
July 1 2022
End Date
January 30 2032
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892